“Medical cannabis laws are associated with significant reductions in opioid prescribing in the Medicare Part D population. This finding was particularly strong in states that permit dispensaries, and for reductions in hydrocodone and morphine prescriptions.”
Related Posts
Pharma Company Funding Anti-Pot Fight Worried About Losing Business, Filings Show
- WOCredentials
- September 13, 2016
- 0
“Pharmaceutical executives who recently made a major donation to an anti-marijuana legalization campaign claimed they were doing so out of concern for the safety of children — but their investor […]
Cannabis link to relieving intestinal inflammation explained
- WOCredentials
- August 18, 2018
- 0
“new research from the University of Massachusetts Medical School and the University of Bath showing that endocannabinoids help control and prevent intestinal inflammation in mice”
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation (2011)
- WOCredentials
- June 16, 2016
- 0
“Treatment with CBD during disease onset ameliorated the severity of the clinical signs of [experimental autoimmune encephalomyelitis]. This effect of CBD was accompanied by diminished axonal damage and inflammation as […]